期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖尿病肾病的防治进展 被引量：6

下载PDF
导出
摘要 糖尿病肾病（diabetic nephropathy，DN）是由糖尿病（DM）本身引起的肾脏损害，临床上以DM患者出现持续性的蛋白尿为主要标志。目前，DN已给社会带来巨大的疾病负担，而其治疗，目前尚无公认、特效的措施。DN的主要防治目标，是防止DN的发生和发展，重在预防。本文就近年来对DN防治方面的一些新进展按是否导致终末期肾病（ESRD）来分类，做一简要综述。
作者 袁启远 薛红 吴红梅
机构地区 四川大学华西医院老年科 成都中医药大学
出处 《现代预防医学》 CAS 北大核心 2007年第9期1679-1681,共3页 Modern Preventive Medicine
关键词 糖尿病 糖尿病肾病 治疗
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献24

  • 1NakamaraT,Us hiyama C,Ossda S,et al.pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with metabolism.Clinical & Experimental[J].2001,50 (10):1193.
  • 2张金黎,陈飞,周艳,徐剑.糖尿病肾病临床治疗新认识与新进展[J].云南医药,2006,27(2):170-172. 被引量：5
  • 3Katayama S.Guidelines for the treatment of hypertension in diabetes[J].NipponRinsho.2006,61 (7):1194-1198.
  • 4Gray A,Clarke P,Farmer A,et al.Implementing intenaive control of blood glucose concentration and blood pressure in type 2 diabetes in England:cost analysis (UKPDS 63)[J].BMJ,2002,325 (7369):860.
  • 5CDC Diabetes Cost-effectiveness Group.Cost-effectiveness of intensive glycemic control,intensified hypertension control,and serum cholesterol level reduction for type 2 diabetes[J].JAMA,2002,287:2542-2551.
  • 6Parring HH,Osterby R,Anderson PW,et al.Diabetic Nephropathy.In Brenner BM Ed.The Kidney[M].Philadelphia,PA:w.B.Saunders,1996.1864-1892.
  • 7Di Paolo S,Gesualdo L,Ranieri E,et al.High glucose concentration induces the overexpression of transfotruing growth factor-beta through the activation of platelet -derived growth factor loop in human mesangial cells[J].American Journal of Pathology,1996,149 (6):2095-2106.
  • 8Ravid M,Broth D,Levi Z,et al.Use of enalapril to attenuate decline in renal function in normotensive,normoalbuminuric patients with type Ⅱ diabetes mellitus.A randomized controiled trial[J].Annals of Internal Medicine,1998,128 (12):982-988.
  • 9Gazis A,Page SR,Cockcroft JR.ACE inhibitors,diabetes and cardiovascular disease[J].Diabetologia,1998,41 (5):595-597.
  • 10Strippoli GF,Craig JC,Craig M,et al.Antihypertensive agents for preventing diabetic nephropathy and retarding its progression:a systematic review of randomized controlled trials (RCTs)[J].Nephrology,2002,7 (suppl ⅩⅩ):S63.

二级参考文献31

  • 1[1]Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glonerular permeability to macromolecules? Kindney Int, 1990, 38 (3):384 ～ 394.
  • 2Hass M, Kerjaschki D, Mayer G. Lipid-lowering therapy in membranous nephropathy. Kidney Int Suppl, 1999,71:S110.
  • 3Buemi M, Allegra A, Corica F,et al. Effect of fluvastation on proteinuria in patients with immunoglobulin A nephropathy. Clin Pharmacol Ther,2000,67 (4):427.
  • 4Zoja C,Coma D,Rottoli D,et al. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kidney Int,2002,61(5):1635.
  • 5leiri N, Hotta O, Taguma Y. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis,2003,41 (2):244.
  • 6Yamamoto T, Yamashita T. Low density lipoprotein apheresis using the Liposorber system:features of the system and clinical benefits. Ther Apher,1998,2(1):25.
  • 7Buyukkocak S,Ozturk HS, Tamer MN, et al.Erythocyte oxidant/arthoxidant status of drabetic patients[ J]. J Endocrinol Invest, 2000,23(4) :228-230.
  • 8Bhatt DL,Topol EJ. Antiplatelet and anticoagulant therapy in the seconday prevention of ischemic heart disease[J]. Med Clin North Am,2000,84( 1 ) : 163-179.
  • 9Gazis A,Page SR, Cockcroft JR. ACE inhibitors,diabetes and cardiovascular disease[ J] .Diabetologia, 1998,41(5) :595-597.
  • 10Bidani AK, Schwarts M, Lewis E. Renal autoregulation and vulnerability to hypertensive ingury in remnant kidney[J]. Am J Physiol, 1997,252(6 Pt 2) :1003.

共引文献117

同被引文献112

引证文献6

二级引证文献32

现代预防医学
2007年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部